2）．50歳以上の者に対する帯状疱疹の予防。 用法・用量 本剤を添付の溶剤（日本薬局方注射用水）0．7mLで溶解し、通常、その0．5mLを1回皮下に注射する。 （用法及び用量に関連する注意） 7．1．〈水痘の予防〉接種対象者 〈水痘予防 ...

Spanish biopharmaceutical company Biofabri and nonprofit scientific research organization IAVI announced today that the first ...

Despite decades of efforts, tuberculosis remains a global health crisis, claiming over 1.3 million lives annually. In a ...

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

2008年に日本大学に戻り、微生物学分野の助手として新しい結核・NTMワクチン開発への挑戦を始めた相澤先生。従来のBCGよりも効果的に結核菌の感染を抑えられるワクチンを生み出す成果を挙げました。各大学の卒業生をインタビューでつなぐ本企画、日本大学リレー・相澤志保子先生の最終回は、2024年に日本大学医学部病態病理学微生物学分野教授に就任された、現在に至るまでのお話です。

Working toward more effective tuberculosis (TB) vaccines, researchers at Weill Cornell Medicine have developed two strains of ...

2008年に日本大学に戻り、微生物学分野の助手として新しい結核・NTMワクチン開発への挑戦を始めた相澤先生。従来のBCGよりも効果的に結核菌の ...

Working towards more effective tuberculosis (TB) vaccinations, researchers at Weill Cornell Medicine have developed two ...

Researchers have engineered two mycobacterial strains with built-in kill switches that trigger self-destruction after immune ...

Innovative research at Weill Cornell Medicine introduces engineered mycobacteria strains with 'kill switches' for safer TB ...

A new LNP-mRNA vaccine significantly boosts immune response and enhances BCG protection against tuberculosis, offering a ...

Australian researchers have developed a new mRNA vaccine for tuberculosis, showing effective results in mice. The vaccine ...